| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |